Nordhealth AS
OSE:NORDH
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Intrinsic Value
Nordhealth AS is a cloud-based healthcare software-as-a-service company. [ Read More ]
The intrinsic value of one NORDH stock under the Base Case scenario is 172.13 NOK. Compared to the current market price of 33.7 NOK, Nordhealth AS is Undervalued by 80%.
Valuation Backtest
Nordhealth AS
Run backtest to discover the historical profit from buying and selling NORDH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Nordhealth AS
Current Assets | 33.4m |
Cash & Short-Term Investments | 27.5m |
Receivables | 4.8m |
Other Current Assets | 1m |
Non-Current Assets | 64.8m |
Long-Term Investments | 834k |
PP&E | 573k |
Intangibles | 62.8m |
Other Non-Current Assets | 615k |
Current Liabilities | 9.9m |
Accounts Payable | 869k |
Accrued Liabilities | 4.2m |
Other Current Liabilities | 4.8m |
Non-Current Liabilities | 270k |
Other Non-Current Liabilities | 270k |
Earnings Waterfall
Nordhealth AS
Revenue
|
35.2m
EUR
|
Cost of Revenue
|
-5.1m
EUR
|
Gross Profit
|
30.1m
EUR
|
Operating Expenses
|
-41.9m
EUR
|
Operating Income
|
-11.9m
EUR
|
Other Expenses
|
-148k
EUR
|
Net Income
|
-12m
EUR
|
Free Cash Flow Analysis
Nordhealth AS
EUR | |
Free Cash Flow | EUR |
NORDH Profitability Score
Profitability Due Diligence
Nordhealth AS's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Nordhealth AS's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
NORDH Solvency Score
Solvency Due Diligence
Nordhealth AS's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
Nordhealth AS's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NORDH Price Targets Summary
Nordhealth AS
According to Wall Street analysts, the average 1-year price target for NORDH is 42.84 NOK with a low forecast of 42.42 NOK and a high forecast of 44.1 NOK.
Shareholder Return
NORDH Price
Nordhealth AS
Average Annual Return | -22.16% |
Standard Deviation of Annual Returns | 27.08% |
Max Drawdown | -65% |
Market Capitalization | 2.7B NOK |
Shares Outstanding | 79 045 109 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Nordhealth AS is a cloud-based healthcare software-as-a-service company. The company is headquartered in Molde, More Og Romsdal. The company went IPO on 2021-06-03. The firm's flagship products are Provet Cloud and Diarium, both cloud-based Practice Management Software for veterinarians and therapists, respectively. The Group serves over 7,000 clinics and hospitals located in over 25 countries. Nordhealth's mission is to build software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business.
Contact
IPO
Employees
Officers
The intrinsic value of one NORDH stock under the Base Case scenario is 172.13 NOK.
Compared to the current market price of 33.7 NOK, Nordhealth AS is Undervalued by 80%.